Navigation Links
The GADA Group Ltd. ("GADA") Welcomes its new Shareholder, RBS Equity Finance ("RBEF")
Date:7/1/2011

LONDON, July 1, 2011 /PRNewswire/ --


 

GADA, one of the leading European healthcare distributors and providers of specialized services for public and private hospital facilities in Italy, Romania and Turkey, is proud to announce an investment by new shareholder RBEF.

GADA supplies a broad range of integrated services to public and private healthcare facilities, including the distribution of high-tech medical devices and disposables, clinical and maintenance services, and was incorporated in Italy in the late 1970s. Today the company is a unique and easily scalable platform, with multi-regional distribution from 2009, following the acquisition of a leading Romanian distributor and entry into Turkey.

During the past 5 years, GADA has doubled its revenues and consistently strengthened its balance sheet. In particular, an intensive consolidation project has been commenced, positioning GADA for the next stage of its pan-European expansion plan.

RBEF is investing significant equity to support GADA's expansion in existing operating countries and to finance further acquisitions across Central and Eastern Europe. RBEF's funding and significant experience will support continuing improvements to the existing offering and accelerate growth through further selective acquisitions.

Sante Giovanni Albonetti, CEO of the GADA Group, said of the investment: "GADA has achieved a number of important milestones during the past decade and this success is paying off, as evidenced by the arrival of an important institutional partner. We are very enthusiastic about the entry of RBEF into the shareholder group and look forward to working together to deliver the next phase of our expansion plan. This investment marks an excellent result for the company and will greatly benefit our current and future associates, suppliers and customers."

Andrew Lawley, Managing Director of RBS Equity Finance, added: "Gada is a leading European medical technology distributor with an exceptional range of opportunities to pursue. We are extremely pleased to have made this investment and look forward to actively support the company in delivering its organic and acquisition plans."

About The GADA Group:

GADA is a leading pan-European supplier of integrated services to public and private healthcare facilities in Italy, Romania and Turkey. Its headquarters are located in London, UK.

http://www.gadagroup.com

About RBS Equity Finance:

RBS Equity Finance manages the RBS Special Opportunities Fund, a £1.1bn fund with a broad investment mandate, covering everything from majority equity investment through to mezzanine debt. This makes them an excellent partner for high quality, growth-focused businesses, as well as a provider of M&A expertise and capital in acquisition-led growth scenarios. RBS Special Opportunities Fund currently backs over 20 companies across a variety of sectors and has a strong track record in a range of sectors. http://www.am.rbs.com

 


For further information, please contact:

The GADA Group

Daniel J. Novacek, Tel: +44-7912-514-029

For media enquiries call Alex Simmons, Smithfield, +44-20-7360-4900

RBS Equity Finance

Andrew Lawley, Tel +44-20-7085-8364


'/>"/>
SOURCE The Gada Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. OM Group Announces Retirement Plans of Chief Financial Officer Kenneth Haber
2. MiMedx Group Receives FDA Clearance to Market Its HydroFix™ Ortho Shield™ Device
3. Foundation Venture Capital Group Invests in Company Developing Plaque-Reducing Dental Hygiene Products
4. ANF Group, Inc. Completes New Joe DiMaggio Childrens Hospital
5. Unity Management Group, MCC Announce Increased Contracts and Major Installations at US and South American Pharmaceutical Companies
6. Nolan Law Group: Jury Finds Against Baxter Healthcare In Nations First Contaminated Chinese Heparin Case
7. Assured Pharmacy Engages The Investor Relations Group
8. Caliper Owners Group Meeting Showcases Transformative Technologies for Advancing Personalized Medicine
9. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
10. Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement
11. HealthPartners and The Chartis Group Collaborate to Improve Health Care Quality, Service, and Cost
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Dec. 2, 2016 The U.S. Food and ... (empagliflozin) to reduce the risk of cardiovascular death in ... disease. "Cardiovascular disease is a leading ... mellitus," said Jean-Marc Guettier , M.D., C.M., director ... FDA,s Center for Drug Evaluation and Research. "Availability of ...
(Date:12/2/2016)... , December 2, 2016 Persistence ... pacemaker market in its upcoming report titled, "Global Market Study on ... Declining CAGR of -1.4% between 2016 and 2024". The global ... in 2015 and this is likely to decline to ... the global cardiac pacemaker market is anticipated to exhibit ...
(Date:12/2/2016)... NEW YORK , December 2, 2016 ... Market Research titled "Global Market Study on Automated Endoscope Reprocessors: ... Register a CAGR of 8.6% Between 2016 and 2024 " the ... 2015 and is expected to expand at a CAGR of ... market valuation of US$ 1,367.6 Mn by 2024. ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... ... More than half of American teens report losing their virginity before they ... child about sex related topics, less than 60 percent spoke about deeper themes like ... launch of its second edition of the “Sexual Wellness” campaign, aiming to address the ...
(Date:12/2/2016)... ... December 02, 2016 , ... Universal Medical ... systems and the first company to offer robotic imaging to veterinary medicine is ... booth # 941 for the American Association of Equine Practitioners 62nd Annual Convention ...
(Date:12/2/2016)... Viejo, California (PRWEB) , ... December 02, 2016 , ... ... will allow FCPX editors to create versatile lower third titles with just a few ... , Pro3rd Accents Volume 2 includes 30 lower third animations. Choose from various styles ...
(Date:12/2/2016)... Pass, OR (PRWEB) , ... December 02, 2016 ... ... Wein, Medical Technologist/Clinical Laboratory Scientist & Author of Type 2 Diabetes: The Owner’s ... host of The Sharon Kleyne Hour Power of Water, Global Climate Change and ...
(Date:11/30/2016)... ... 2016 , ... "I hate when the mixture of saliva and toothpaste runs ... inventor from Bridgewater, N.J. "I thought that there had to be a way to ... the patent-pending DEFLECTOR to prevent saliva and toothpaste from running down the brush handle ...
Breaking Medicine News(10 mins):